UPDATE2: Fire in under-construction Tokyo tall building injures 4 people

Japan Economic Newswire |

A fire broke out in a high-rise building under construction near a bustling Tokyo railway station on Friday, leaving four men injured, but all remained conscious, firefighters and police said.

A plume of black smoke was visible after rising from the upper part of the building, which has 27 floors and two basement floors, and is located in one of the Japanese capital's major business districts about 300 meters northwest of JR Shimbashi Station.

The fire was extinguished about two hours later after roughly 100 square meters of the rooftop portion of the building were burned, they said, adding some 360 construction workers were in the building, out of which about 30 were on the rooftop, at the time.

Local police said they believe sparks from a burner fell on urethane insulation on the rooftop and ignited the fire.

The building was expected to be completed in July and will house shops and a hotel, according to its construction plan.

A number of fire trucks surrounded the building, while several helicopters circled overhead. A 58-year-old man who was cleaning the 15th floor said, "I thought I had to escape very quickly after seeing people were coming down one after another from upper floors."


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…